These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33485792)

  • 41. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
    Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
    Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection.
    Cai X; Gao F; Qi Y; Lan G; Zhang X; Ji R; Xu Y; Liu C; Shi Y
    Eur Radiol; 2020 Sep; 30(9):5158-5169. PubMed ID: 32346792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of pancreatic steatosis prevalence and anthropometric measurements using non-contrast computed tomography.
    Koç U; Taydaş O
    Turk J Gastroenterol; 2020 Sep; 31(9):640-648. PubMed ID: 33090101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of Pancreatic Steatosis at a Pediatric Tertiary Care Center.
    Pham YH; Bingham BA; Bell CS; Greenfield SA; John SD; Robinson LH; Eissa MA
    South Med J; 2016 Mar; 109(3):196-8. PubMed ID: 26954660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Visual enhancement pattern during the delayed phase of enhanced CT as an independent prognostic factor in stage IV pancreatic ductal adenocarcinoma.
    Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nagano H; Hidaka S; Kamimura K; Maemura K; Arima S; Yoshiura T
    Pancreatology; 2020 Sep; 20(6):1155-1163. PubMed ID: 32800574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy.
    Amer AM; Zaid M; Chaudhury B; Elganainy D; Lee Y; Wilke CT; Cloyd J; Wang H; Maitra A; Wolff RA; Varadhachary G; Overman MJ; Lee JE; Fleming JB; Tzeng CW; Katz MH; Holliday EB; Krishnan S; Minsky BD; Herman JM; Taniguchi CM; Das P; Crane CH; Le O; Bhosale P; Tamm EP; Koay EJ
    Cancer; 2018 Apr; 124(8):1701-1709. PubMed ID: 29370450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer.
    Mellby LD; Nyberg AP; Johansen JS; Wingren C; Nordestgaard BG; Bojesen SE; Mitchell BL; Sheppard BC; Sears RC; Borrebaeck CAK
    J Clin Oncol; 2018 Oct; 36(28):2887-2894. PubMed ID: 30106639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
    Chang DZ; Ma Y; Ji B; Liu Y; Hwu P; Abbruzzese JL; Logsdon C; Wang H
    J Hematol Oncol; 2012 Apr; 5():15. PubMed ID: 22475564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens.
    Ma C; Yang P; Li J; Bian Y; Wang L; Lu J
    Abdom Radiol (NY); 2020 Mar; 45(3):782-788. PubMed ID: 31292672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differentiation of benign and malignant solid pancreatic masses using magnetic resonance elastography with spin-echo echo planar imaging and three-dimensional inversion reconstruction: a prospective study.
    Shi Y; Gao F; Li Y; Tao S; Yu B; Liu Z; Liu Y; Glaser KJ; Ehman RL; Guo Q
    Eur Radiol; 2018 Mar; 28(3):936-945. PubMed ID: 28986646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aspirin Use and Risk of Pancreatic Ductal Adenocarcinoma: A Large Case-Control Study.
    Momayez Sanat Z; Masoudi S; Tabaeian SP; Jameh Shorani M; Soruri M; Pourshams A
    Arch Iran Med; 2023 Apr; 26(4):181-185. PubMed ID: 38301077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Usefulness of
    Yokose T; Kitago M; Matsusaka Y; Masugi Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Endo Y; Toyama K; Iwabuchi Y; Takemura R; Ishii R; Nakahara T; Okuda S; Jinzaki M; Kitagawa Y
    Cancer Med; 2020 Jun; 9(12):4059-4068. PubMed ID: 32281301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Objective and subjective comparison of virtual monoenergetic vs. polychromatic images in patients with pancreatic ductal adenocarcinoma.
    Beer L; Toepker M; Ba-Ssalamah A; Schestak C; Dutschke A; Schindl M; Wressnegger A; Ringl H; Apfaltrer P
    Eur Radiol; 2019 Jul; 29(7):3617-3625. PubMed ID: 30888484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum biomarker panels for the detection of pancreatic cancer.
    Brand RE; Nolen BM; Zeh HJ; Allen PJ; Eloubeidi MA; Goldberg M; Elton E; Arnoletti JP; Christein JD; Vickers SM; Langmead CJ; Landsittel DP; Whitcomb DC; Grizzle WE; Lokshin AE
    Clin Cancer Res; 2011 Feb; 17(4):805-16. PubMed ID: 21325298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.
    Park S; Chu LC; Hruban RH; Vogelstein B; Kinzler KW; Yuille AL; Fouladi DF; Shayesteh S; Ghandili S; Wolfgang CL; Burkhart R; He J; Fishman EK; Kawamoto S
    Diagn Interv Imaging; 2020 Sep; 101(9):555-564. PubMed ID: 32278586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is diabetes onset at advanced age a sign of pancreatic cancer?
    Ozsay O; Karabacak U; Cetin S; Majidova N
    Ann Ital Chir; 2022; 93():476-480. PubMed ID: 36156490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
    Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
    Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simulated twin-phase pancreatic CT generated using single portal venous phase dual-energy CT acquisition in pancreatic ductal adenocarcinoma.
    Noda Y; Tochigi T; Parakh A; Kambadakone A
    Abdom Radiol (NY); 2021 Jun; 46(6):2610-2619. PubMed ID: 33454806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging features of pancreatic metastases: A comparison with pancreatic ductal adenocarcinoma.
    Galia M; Albano D; Picone D; Terranova MC; Agrusa A; Di Buono G; Licata A; Lo Re G; La Grutta L; Midiri M
    Clin Imaging; 2018; 51():76-82. PubMed ID: 29448123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.